Atorvastatin Attenuates Endothelial Cell Injury in Atherosclerosis Through Inhibiting ACSL4‐Mediated Ferroptosis
Cardiovascular Therapeutics · 2024
DOI: 10.1155/2024/5522013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Therapeutics, 2024. Verfasst von Huilian Tan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Human Umbilical Vein Endothelial Cells, Atorvastatin, Ferroptosis, Coenzyme A Ligases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study is aimed at investigating the effects of atorvastatin (ATV) on endothelial cell injury in atherosclerosis (AS) through inhibiting acyl‐CoA synthetase long‐chain family member 4 (ACSL4)‐mediated ferroptosis.
Methods
Human umbilical vein endothelial cells (HUVECs) were treated with oxidized low‐density lipoprotein (ox‐LDL) to establish an in vitro model of AS. The cell viability, lactate dehydrogenase (LDH) release, apoptosis, and expression levels of apoptotic proteins were assessed. The levels of inflammatory factors and adhesion molecules were determined by ELISA and Western blot, respectively. Cellular iron content, lipid peroxidation, glutathione (GSH) levels, and lipid reactive oxygen species (ROS) were measured. ACSL4 overexpression was performed to investigate its role in ATV‐mediated protection against ferroptosis.
Results
ATV alleviated ox‐LDL‐induced HUVEC damage by restoring cell viability, reducing LDH levels, and inhibiting apoptosis. It also attenuated inflammation and adhesion by decreasing the levels of inflammatory factors TNF‐ α , IL‐6, and IL‐8, as well as adhesion molecules ICAM‐1 and VCAM‐1. ATV inhibited ferroptosis by regulating iron content, malondialdehyde (MDA) levels, ROS levels, and ACSL4 protein expression. Overexpression of ACSL4 (oe‐ACSL4) hindered the protective effects of ATV on cell viability, antiapoptotic protein expression, LDH levels, apoptosis, and inflammatory factors.
Conclusion
Our findings suggest that ATV attenuates endothelial cell injury in AS by inhibiting ACSL4‐mediated ferroptosis. These results provide insights into the potential therapeutic strategies for the treatment of AS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
ORCID-Profile: Jun Liu
Zitieren
APA
Tan, H., Liu, L., Qi, Y., Zhang, D., Zhi, Y., Li, Y., Zhang, H., & Liu, J. (2024). Atorvastatin Attenuates Endothelial Cell Injury in Atherosclerosis Through Inhibiting ACSL4‐Mediated Ferroptosis. Cardiovascular Therapeutics. https://doi.org/10.1155/2024/5522013
Vancouver
Tan H, Liu L, Qi Y, Zhang D, Zhi Y, Li Y, et al. Atorvastatin Attenuates Endothelial Cell Injury in Atherosclerosis Through Inhibiting ACSL4‐Mediated Ferroptosis. Cardiovascular Therapeutics. 2024. doi:10.1155/2024/5522013
BibTeX
@article{Tan2024,
author = {Tan, Huilian and Liu, Ling and Qi, Yanchao and Zhang, Dahong and Zhi, Yanchun and Li, Yu and Zhang, Huimin and Liu, Jun},
title = {Atorvastatin Attenuates Endothelial Cell Injury in Atherosclerosis Through Inhibiting ACSL4‐Mediated Ferroptosis},
journal = {Cardiovascular Therapeutics},
year = {2024},
doi = {10.1155/2024/5522013}
}
EUVIMED